Inhibition of TGF-beta expression: a novel role for thiazolidinediones to implement renoprotection in diabetes.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18046419.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Actual strategies to delay progression of diabetic nephropathy provide imperfect protection when started late in the course of the disease. Ohtomo et al. now demonstrate that thiazolidinedione treatment was associated with a remarkable improvement in proteinuria and renal function, offering a new potential treatment for diabetic nephropathy.
Medical subject headings
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Thiazolidinediones
- Transforming Growth Factor beta